Table 2.
Reported barriers to HPV Vaccination
| Barriers | N non-vaccinated group (n = 205) | % |
|---|---|---|
| The vaccine costs too much | ||
| Influential | 90 | 45.69 |
| Neutral | 24 | 12.18 |
| Not Influential | 60 | 30.46 |
| N/Aa | 23 | 11.68 |
| The vaccine is not covered by my health insurance | ||
| Influential | 78 | 39.59 |
| Neutral | 25 | 12.69 |
| Not Influential | 60 | 30.46 |
| N/A | 34 | 17.26 |
| I don’t know enough about the vaccine | ||
| Influential | 107 | 54.31 |
| Neutral | 20 | 10.15 |
| Not Influential | 49 | 24.87 |
| N/A | 21 | 10.66 |
| I don’t know enough about the vaccine’s potential side effects | ||
| Influential | 126 | 66.64 |
| Neutral | 18 | 9.09 |
| Not Influential | 37 | 18.69 |
| N/A | 17 | 8.59 |
| I don’t know if the vaccine works | ||
| Influential | 95 | 47.98 |
| Neutral | 35 | 17.68 |
| Not Influential | 53 | 26.77 |
| N/A | 15 | 7.58 |
aN/A: the participant does not think the barrier is applicable to her situation